Beranda › Fibrosis Paru Idiopatik › Michigan
Uji klinis Fibrosis Paru Idiopatik di Michigan
7 studi untuk Fibrosis Paru Idiopatik mencari peserta di lokasi di Michigan.
Kota di Michigan
Teks studi resmi (Bahasa Inggris)
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Research Site, Ann Arbor
- Research Site, Detroit
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07652658RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of Michigan, Ann Arbor
- Henry Ford Health, Novi
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT07002034A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- Henry Ford Health, Detroit
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT06968845Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
- University of Michigan Health System - Ann Arbor /ID# 279994, Ann Arbor
- Henry Ford Hospital /ID# 277843, Detroit
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07230288Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- Beaumont Hospital, Royal Oak, Royal Oak
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT05571059Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Henry Ford Health, Detroit
Menerima pesertaStudi observasional
Usia 21 ke atas · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT01915511WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- WISPer Site in Ann Arbor, MI, Ann Arbor
- WISPer Site in Detroit, MI, Detroit
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT06967805Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.